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ABSTRACT
Objectives: The aim of this study is to evaluate the short-term outcomes of our modified autologous transobturator tape 
(aTOT) technique with rectus abdominis muscle fascial graft for the treatment of female stress urinary incontinence (SUI).
Material and methods: The data of 22 patients who underwent modified aTOT were recorded. Perioperative data regard-
ing operative time, complications and postoperative visual analogue scores were noted. Patients were assessed 18 months 
after surgery. The primary endpoints of this study were the improvements in the International Consultation on Incontinence 
Questionnaire-Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) subscores, one-hour pad test and cough stress test 
rates as an objective cure as well as the improvements in the PGI-I and ICIQ-FLUTS quality of life scores as a subjective cure. 
Results: Mean age and the mean follow-up period were 51.7 ± 9.8 years and 20.1 ± 0.9 months, respectively. Urethral 
hypermobility and a positive cough stress test were detected in all the patients. Mean operative time was 43.8 ± 8.1 min. 
and the overall complication rate was 9%. Mean VAS scores at postoperative 24 hours were 2.6 ± 1.2. At the postoperative 
eighteenth month, no patient had a positive cough test and mean PGI-I score was 2 while two patients had moderate 
urinary incontinence according to the pad test. Pad test results, ICIQ subscores of voiding QoL, incontinence, incontinence 
QoL, total score and total QoL score at baseline and eighteen months after surgery were 76.9 ± 19.9, 9.6 ± 4.1, 15.5 ± 4.0, 
39.5 ± 7.9, 27.9 ± 6.6, 68.4 ± 13.8 and 7.1 ± 2, 10.1 ± 2.4, 6.6 ± 2.1, 13.4 ± 4.5, 20.4 ± 4.8, 39.7 ± 9.2 respectively (p = 0.001, 
p = 0.004, p = 0.001, p = 0.001, p = 0.001, and p = 0.001, respectively)
Conclusions: Modified aTOT is an effective and safe method with low morbidity for SUI treatment in short term. 
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INTRODUCTION
Mid-urethral sling surgeries (MUSS): transobturator-tape 
(TOT) and retro-pubic tape (RT) with a non-absorbable 
synthetic material are the most common surgical proce-
dures for female stress urinary incontinence (SUI) [1]. The 
advantages of these procedures include a reduced opera-
tive time, a favorable outpatient technique and promising 
long-term outcomes [2]. Nevertheless, a number of unique 
mesh-related complications such as erosion, migration and 
mesh site infection have been reported in up to 2% of the 
cases undergoing MUSS and these complications require 
surgical intervention to revise or remove the mesh [3, 4].
The United States Food and Drug Administration (FDA) 
released public health notifications about mesh usage in 
transvaginal surgeries. FDA classified meshes as class 3 de-
vices (highest risk devices) for pelvic organ prolapse (POP) 
surgery and class 2 for SUI surgery [5]. FDA also noted that 
MUSS are less morbid surgeries, have similar cure rates 
with non-mesh surgeries and cause unique complications 
that are not present in non-mesh surgeries. Although these 
reports did not limit the use of mesh for SUI, MUSS has 
been increasingly questioned by patients, surgeons and 
legal communities after the emergence of these reports 
[6]. Moreover, television advertisements and litigation re-
lated to mesh complications have increased since the FDA 
reports. Although the complication rates remain stable after 
MUSS, the frequency of symptoms reported by patients has 
increased recently [1].
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Current guidelines still recommend MUSS for SUI treat-
ment [7] However, numerous non-mesh techniques have 
been described for SUI surgery over the last decade af-
ter FDA warnings. Accordingly, traditional pubovaginal 
slings (PVS) using autologous rectus muscle fascia have 
been re-popularized [8, 9]. Moreover, Burch colposuspen-
sion surgery (BC) has been shown as a viable option for 
recurrent and primary SUI and urethral bulking agents have 
re-emerged as popular techniques [10, 11]. A number of new 
techniques using autologous tissues based on the surgi-
cal characteristics of MUSS have been described to avoid 
mesh-related complications [1, 12–13]. However, there is no 
consensus on an optimal surgical technique for SUI surgery 
in patients who are unwilling to undergo mesh surgery.
Objectives
MUSS with autologous tissue appears to be a feasible 
option although there is a need for further documentation 
of the benefits of this technique as well as its short- and 
long-term outcomes. The present study aimed to evaluate 
the outcomes of our modified autologous transobturator 
tape (aTOT) technique in patients with SUI.
MATERIAL AND METHODS
Study population
After obtaining an approval from the Institutional Re-
view Board, the study evaluated a total of 22 female patients 
that underwent modified aTOT for SUI between December 
2017 and February 2018. All the patients met the criteria for 
uncomplicated SUI and the exclusion criteria included POP 
greater than grade 2 according to the Pelvic Organ Prolapse 
Quantification (POP-Q) system, pregnancy, history of pelvic 
radiation and SUI surgery, increased post-void residual vol-
ume (PVRV) (greater than 150 cc), poor voiding patterns on 
uroflowmetry and history of neurologic diseases. Patients 
were encouraged for lifestyle modification and pelvic floor 
muscle training for a minimum period of three months after 
the diagnosis of SUI. Indications for surgery included reluc-
tance or dissatisfaction after conservative management. The 
available surgical options and the concerns about synthetic 
meshes were discussed with patients. Modified aTOT was 
performed in each patient who preferred to undergo MUSS 
but refused the use of synthetic meshes and accepted to 
participate in this study protocol.
Diagnostic workup
Patients were evaluated based on a detailed medical 
history, urine culture, pelvic examination including urethral 
hypermobility test (Q-tip test), cough stress test (CST) and 
POP examination and uroflowmetry with measurement of 
PVRV. The Q-tip test was performed in lithotomy position; 
a well-lubricated cotton-tipped swab was introduced into the 
urethra and then resting and straining angles were measured 
at the horizontal plane. A straining angle greater than 30° 
was a threshold for urethral hypermobility [14]. CST was 
performed in the lithotomy position with 200-400 ml urine in 
bladder; urine leakage from urethra after one to three strong 
coughs was associated with a positive result [12].
The International Consultation on Incontinence 
Questionnaire-Female Lower Urinary Tract Symptoms 
(ICIQ-FLUTS), which is a validated form used for the evalua-
tion of lower urinary tract symptoms and quality of life (QoL) 
in three sections (frequency, voiding, and incontinence) 
was administered to each patient. The one-hour pad test, 
which is standardized by the International Continence So-
ciety (ICS) as the measurement of pad weight increase after 
a standard protocol, was used for the objective assessment 
of SUI. The weight gain of the pad was recorded and the 
degree of incontinence was classified into three groups as; 
mild (1–10 g), moderate (10–50 g) and severe (> 50 g) [15]. 
Patients diagnosed with SUI and also suffering from urinary 
incontinence with urgency were classified as mixed urinary 
incontinence (MUI). 
Surgical technique
Our surgical technique was elaborated in a previous 
article [16]. After the induction of general anesthesia, the 
patient was positioned in the lithotomy position and a Foley 
catheter was inserted. After hydrodissection with saline, 
a 2 cm longitudinal vaginal incision was performed at the 
mid-urethral level. Bilateral periurethral dissection was per-
formed until reaching the inferior ischiopubic ramus. A 5* 
1.5 cm rectus fascia was harvested via a 3 cm suprapubic 
transverse incision. Two 2–0 nonabsorbable polyester stay 
sutures (Ethibond®, Ethicon) were placed on the corners 
of the fascial graft on both sides. Two separate punctures 
were performed on both sides over the medial aspect of 
the obturator foramen at the level of the clitoris and the 
dissection was continued to the obturator foramen blindly. 
A TOT needle was passed twice through the foramen and 
the stitches were transferred from the vaginal incision to the 
skin separately. A bridge was established on the obturator 
membrane by separate stitches on both sides. The graft was 
placed in the mid-urethral position without tension and 
sutures were tied to each other on both sides. We didn’t 
perform intraoperative cough test. The incisions were closed 
separately and a vaginal packing was placed at the end of 
the procedure. The urethral catheter and vaginal packing 
were removed and the patient was discharged at the first 
postoperative day. 
Follow-up
Perioperative data regarding operative time and compli-
cations were recorded for each patient. Complications were 
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evaluated and classified based on the Clavien system [17]. 
Visual analogue score (VAS) was performed for pain assess-
ment at postoperative hours 8 and 24. All the patients were 
discharged at the first postoperative day after spontane-
ously voiding at least two-thirds of the total bladder volume 
as confirmed by ultrasonography. At the first postoperative 
week, patients were invited for a clinical evaluation of surgi-
cal wounds and the assessment of surgery-related problems.
During the follow-up, patients were evaluated at 1st, 
3rd, 6th and 18th months after surgery. At the postoperative 
eighteenth months, patients were evaluated with stress test, 
the one-hour pad test, ICIQ-FLUTS and the Patient Global 
Impression of Improvement (PGI-I) scale. For each patient 
the necessity of further surgery due to complications or 
failure was noted.
The primary endpoints of this study were the improve-
ments in the ICIQ-FLUTS subscores, one-hour pad test and 
cough stress test rates as an objective cure as well as the 
improvements in the PGI-I and ICIQ-FLUTS quality of life 
scores as a subjective cure. 
Statistical analysis
Data were analyzed using Statistical Package for Social 
Sciences (SPSS) for Windows version 20.0 (Armonk, NY: IBM 
Corp.). Categorical variables were presented as frequen-
cies (n) and percentages (%). Continuous variables were 
presented as mean ± standard deviation (SD) and were 
compared using a paired Student’s t-test. A two-tailed 
p value of < 0.05 was considered significant.
RESULTS
The 22 patients with a mean age of 51.7 ± 9.8 years 
enrolled in this study. Preoperatively, 16 (72.7%) patients 
had pure SUI and 6 (27.3%) patients had stress-dominant 
MUI (Tab. 1). Mean follow-up period was 20.1 ± 0.9 months.
Urethral hypermobility and a positive cough stress test 
were detected in all the patients. Mean pad weight gain 
was 76.9 ± 19.9 g in the one-hour pad test and the test 
also showed moderate and severe urinary incontinence in 
6 (27.3%) and 16 (72.7%) patients, respectively. Mean op-
erative time was 43.8 ± 8.1 min and the overall complica-
tion rate was 9% (2/22) (Clavien Grade 1). One patient had 
wound infection on suprapubic incision and one had vaginal 
exposure of fascial graft smaller than 1 cm. Both patients 
were treated conservatively without any further surgical 
intervention. Mean VAS scores at postoperative hours 8 and 
24 were 6.2 ± 0.8 and 2.6 ± 1.2, respectively (Tab. 2). No pa-
tient was diagnosed with urinary retention and urogenital 
tract infection during the follow up period. 
Table 3 presents a comparison of pre- and post-oper-
ative findings. In the postoperative eighteenth month, no 
patient had a positive cough test. Mean pad weight gain was 
76.9 vs 7.1 gr in the pad test at baseline and postoperative 
eighteenth month, respectively (p = 0.001). Two patients 
had moderate urinary incontinence at postoperative eigh-
teenth month according to pad test. The mean PGI-I score 
was 2 postoperatively. ICIQ subscores of voiding QoL, in-
continence, incontinence QoL, total score and total QoL 
Table 1. Patients’ characteristics
Age [year]* 51.7 ± 9.8
BMI [kg/m2]* 28.8 ± 3.9
Number of births* 3.2 ± 1.2
Vaginal birth* 2.9 ± 1.6
Cesarean* 0.4 ± 0.8
Assisted vaginal birth** NA
Pelvic surgery history 1 (4.5%)
Menopause 9 (40.9%)
Incontinence (pure stress/mixed) 16/6
Diabetes mellitus 2 (9.1%)
* — mean + standard deviation; **— births with vacuum and forceps devices; 
NA — not available; BMI — body mass index
Table 2. Operative and post-operative data
Operation time [minutes]* 43.8 ± 8.1
VAS score (post op 8. hours)* 6.2 ± 0.8
VAS score (post op 24. hours)* 2.6 ± 1. 2
Complication
Grade 1 2 (9%)
Grade 2 0
Grade 3 0
Duration of follow up (months)* 20.1 ± 0.9
* — mean + standard deviation
Table 3. Comparison of values at the baseline and at 18 months 
after surgery
Baseline 18th months p
ICIQ Frequency* 8.1 ± 2.8 8.4 ± 2.8 0.557
ICIQ Frequency QoL* 19.3 ± 7.3 16.3 ± 5.7 0.156
ICIQ Voiding * 4.2 ± 2.3 5.3 ± 1.4 0.095
ICIQ Voiding QoL* 9.6 ± 4.1 10.1 ± 2.4 0.004
ICIQ Incontinence* 15.5 ± 4.0 6.6 ± 2.1 0.001
ICIQ Incontinence QoL* 39.5 ± 7.9 13.4 ± 4.5 0.001
ICIQ Total Score* 27.9 ± 6.6 20.4 ± 4.8 0.001
ICIQ Total QoL Score* 68.4 ± 13.8 39.7 ± 9.2 0.001
Ped Test [gr/hour]* 76.9 ± 29.9 7.1 ± 2 0.001
Stress Test + 22 0 0.001
* — mean + standard deviation
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score at baseline and eighteen months after surgery were 
9.6 ± 4.1, 15.5 ± 4.0, 39.5 ± 7.9, 27.9 ± 6.6, 68.4 ± 13.8, and 
10.1 ± 2.4, 6.6 ± 2.1, 13.4 ± 4.5, 20.4 ± 4.8, 39.7 ± 9.2 respec-
tively (p = 0.004, p = 0.001, p = 0.001, p = 0.001, and p = 0.001, 
respectively). At postoperative eighteenth month patients 
had not any complaints about pain. 
DISCUSSION
The subjective cure and postoperative satisfaction rates 
of MUSS, PVS and BC vary from 62 to 98% in the literature. 
This range was associated with the diversity of the defini-
tions of incontinence and also with the tools for measuring 
patient satisfaction [18]. Ford et al. [19] reported that the 
average subjective cure rates (improvement in any type of 
incontinence) for both TOT and RT at the postoperative first 
and fifth years were 83% and 84%, respectively. Brubaker 
et al. [20] further analyzed the findings of their previously 
published SISTer study and reported that the patients’ sat-
isfaction rates after PVS and BC decreased slightly between 
the second and fifth postoperative years, with a decrease 
from 79% to 73% for BC and from 87% to 83% for PVS. In the 
present study, the subjective cure rate was 100% according 
to the PGI-I scores and the improvements in QoL scores. Our 
findings are comparable with the findings of studies with 
a follow-up of up to two years; however, longer term findings 
are needed for a comparison with the findings of studies 
with longer follow-up periods.
Albo et al. evaluated objective cure rates after SUI sur-
geries and suggested that despite strict definitions of ob-
jective cure such as; negative cough stress test, negative 
values on one hour or 24 hours pad test and no record of 
incontinence on three days voiding diaries and urodynamic 
investigations, it is impossible to compare studies due to 
variation of these definitions [20, 21]. Ford et al. reported the 
objective cure rates at the first and fifth postoperative years 
as 85% and 82% for TOT and as 87% and 85% for RT, respec-
tively [19]. Palos et al. reported that the objective cure rates 
of TOT and RT were 100% and 92% at postoperative month 
12, respectively [22]. In SISTer trial, Albo et al. [21] reported 
the objective cure rates for PVS and BC at the second year 
as 66% and 49%, respectively. In another study, Maggiori et 
al [23] reported lower objective cure rates in the fifth year, 
with 30% for PVS and 24% for BC and reported that the 
majority of the study population probably consisted of the 
incontinent participants of the previous study. In the present 
study, objective cure rate was calculated as 100% based on 
the one-hour pad test and cough stress test results. This 
finding implicates that the usage of autologous graft in 
mid-urethral sling surgery does not reduce the short-term 
effects of the surgery (up to two years) compared to those 
of TOT and RT and thus our technique can be considered to 
provide better outcomes compared to those of BC and PVS.
The analysis of postoperative outcomes indicated that 
two patients had moderate urinary incontinence on the 
one-hour pad test although they had a negative stress test 
result and a score of < 4 on PGI-I. Abdelfettah et al. [24] calcu-
lated a correlation with 96% sensitivity and 93% specificity be-
tween self-assessment questionnaires and the one hour pad 
test. However, Constantini et al [25] suggested that one hour 
pad test has a poor predictive value in diagnosis of female 
SUI. At the present study, there was discordance between pad 
test and the other diagnostic tools. This discordance can also 
be noted among the guidelines; while EAU guidelines recom-
mend the use of pad test, NICE guidelines do not [26, 27].
For the assessment of SUI, detecting urethral hypermo-
bility had an important role in previous literature. Q-type 
test and voiding cystourethrogram can be used to measure 
urethral hypermobility [14]. Walsh at al. [14] concluded that 
although traditionally lower degree of urethral hypermobil-
ity indicates intrinsic sphincter deficiency and PVS is a better 
option for these patients, nowadays it has been a contro-
versial issue due to the lack of a standardized definition and 
measurement techniques. Proper positioning of swab into 
urethra, rigidity of foley catheter and concomitant POP are 
the factors affecting measurements. Nowadays although 
current AUA/SUFU and NICE guidelines don’t recommend 
to routinely use urethral hypermobility measurements at the 
present study it was used not only to detect hypermobility 
but also to detect fixed urethra which is indicated as an im-
portant issue to determine type of incontinence surgery 
type by Walsh at al [7, 14].
Fusco et al. [28] conducted a meta-analysis and reported 
that incontinence surgery resulted in a significant improve-
ment in the QoL measurements of the patients regardless 
of the surgical technique. Palos et al. [29] suggested that 
the improvements in QoL measurements are correlated 
with the objective and subjective cure rates. In the present 
study, significant improvements were also observed in the 
QoL scores for the incontinence subsection and the total 
QoL score of ICIQ-FLUTS for all patients and it was also cor-
related with the continence status of the patients.
Literature indicates that PVS, BC and MUSS have simi-
lar complication rates [29–32]. For instance, perioperative 
bleeding requiring blood transfusion is a serious problem 
associated with all of these procedures and may occur in 
up to 2% of the cases [29–32]. In the present study, how-
ever, no patient had significant blood loss. Another feared 
complication of these three techniques is bowel, bladder 
or urethral injury which has been reported in up to 9% 
of the cases [29–32]. Higher rates were reported after RT 
procedures for bladder, vascular and bowel injuries [18]. 
In contrast, TOT provides technical advantages in terms of 
avoiding perioperative organ injury and has been reported 
to cause bladder or urethra injury in only a limited number 
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of cases [19]. In our study, no perioperative organ injury was 
observed in any patient.
Blavias et al. [30] reported the wound complications 
rate as 3% after PVS. In our study, only one patient (4%) 
was diagnosed with wound infection and was treated with 
non-surgical interventions. A biological graft material is 
needed to avoid the use of synthetic mesh and a Cochrane 
review by Rehman et al. [33] suggested that rectus muscle 
fascia is the most appropriate and most commonly preferred 
material for PVS. Mahdy et al. [31] suggested the use of 
fascia lata when it is impossible to harvest rectus fascia. In 
our study, no material other than rectus fascia was required 
in any patient. In our opinion, it is easy to harvest this fascia 
and usually patients have an incision secondary to previous 
cesarean or other surgical interventions; therefore, it can be 
performed via this incision to avoid a new incision and scar 
on patients. Blavias et al. [25] reported chronic pelvic pain in 
0.6% of the patients. Pelvic pain rates were 0.8% and 2.9% 
while groin pain rates were 6.4% and 0.6% for TOT and RT, 
respectively [18]. The decrease in VAS scores of our patients 
indicates that this pelvic pain disappeared at postoperative 
first day. This result is comparable with literature; however 
we have no data about groin pain. 
Erosion of mesh into the vagina, bladder, or urethra is 
a complication of MUSS, which has been reported in 0.7–2% 
of the cases [2]. No differences were reported among the 
TOT and RT procedures [18]. The etiological factors of this 
complication include inadequate vaginal closure, wound 
infection, early sexual intercourse and excessive tension of 
the sling. In contrast, PVS do not cause mesh erosions due to 
its autologous structure [8, 28]. In our study, no erosion was 
observed, however only one patient had a minimal vaginal 
exposure of fascial graft that was smaller than 1 cm, which 
was successfully treated with topical estradiol. Based on 
these findings, we consider that the usage of autologous 
graft with proper tension is of critical importance for obtain-
ing favorable outcomes.
Abraham et al. [34] suggested that the symptoms of 
de novo urgency are as bothersome for the patients as 
the symptoms of preoperative stress urinary incontinence. 
Mahdy et al. [31] reported the incidences of de novo ur-
gency and urge incontinence after PVS as 15–20% and 7.2%, 
respectively. On the other hand, a similar incidence of de 
novo urgency has been reported for BC and MUSS (10%), 
more common after RT than TOT [18, 30]. Gomez et al. sug-
gested that bladder outlet obstruction, bladder perforation 
and infection are the major causes of de novo urgency [35]. 
In our study, no significant change was observed between 
pre- and post-operative scores of the frequency subsec-
tion of ICIQ-FLUTS. We consider that although MUSS are 
thought to be tension-free procedures, fibrosis secondary 
to mesh placement can cause urethral obstruction in the 
long term; thereby leading to de novo urgency [19, 35]. 
Accordingly, we suggest that autologous graft positioned 
in the mid-urethral region without tension will not cause 
de novo urgency. It can be explained by lower possibility of 
urethral obstruction owing to the very low fibrosis potential 
of autologous graft around the urethra when compared to 
synthetic meshes and by the lack of bladder neck obstruc-
tion secondary to the mid-urethral positioning of fascial 
graft when compared to PVS.
Voiding dysfunction and urinary retention requiring 
urethral catheterization are two well-known complications 
reported after SUI surgery and have been shown to be as-
sociated with urinary bladder detrusor dysfunction and 
iatrogenic urethral obstruction [30–33]. The incidence of 
urinary retention after PVS, BC and MUSS has been reported 
to be 20%, 8%, and 3%, respectively [19, 31–32]. In our study, 
no patient had urinary retention and there was no significant 
difference between pre- and post-operative scores of the 
voiding subsection of ICIQ-FLUTS. These findings could be 
attributed to two factors: the adequate preoperative detru-
sor contractility of all the patients assessed by uroflowmetry 
(patients with intermittent flow patterns and high residual 
urine volumes were not included in the study) and the 
tension-free nature of our technique.
Veit-Rubin et al. [10] detected POP in 25% of the pa-
tients that underwent BC. In contrast, PVS, MUSS and also 
the method used in the present study have no risk of POP 
formation as they do not require pelvic dissection which 
distorts urethral support during surgery, as in BC [28, 29].
To our knowledge, the use of autologous tissue in 
MUSS has been investigated in a small patient series with 
short-term results [1, 12–13]. El-Gamal et al. used a hybrid 
mesh for TOT in 44 patients, which was an elongated rectus 
fascia with synthetic non-absorbable mesh on both edges 
[12]. The cure rates were remarkably high (92%) and the 
complication rates were comparable with MUSS however 
their method could not be considered as a non-mesh sur-
gery. Linder et al. developed an autologous transobturator 
sling technique [1]. They reported retreatment-free survival 
rate as 75% in the postoperative 18 months. The authors 
used an absorbable suture to elongate the rectus fascia and 
in our opinion after breaking down of these sutures, autolo-
gous tissue lost its tension and position [1]. This problem 
might be a cause of long-term treatment failure. Osman et al. 
described a novel technique called ‘sling on a string’, in which 
rectus fascia is positioned as a classic RT mesh. The authors 
published their results from 106 patients with a follow-up of 
9 months and reported that their results were comparable to 
those of MUSS although their technique resulted in longer 
hospital stays (5.6 days) [13].
The present study contributes to the literature in terms 
of surgical modifications. However, it had some limitations 
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such as short follow-up period, small number of patients 
and the absence of cost analysis.
CONCLUSIONS
Modified aTOT is an effective and safe method with low 
morbidity for SUI treatment in short term. 
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